Iterum Therapeutics is a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens.
2025/5/3 3:51:08
(ITRM:NASDAQ)